“In Silico Molecular Docking Studies of Cell-Penetrating Peptide and Doxorubicin toward Multiple Tumor Receptors” (2024) Asian Journal of Pharmaceutics (AJP), 18(01). doi:10.22377/ajp.v18i01.5274.